AbCellera Biologics Inc vs EPR Properties — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while EPR Properties trades at $60 (market cap $4.58B). The key difference: EPR Properties is the larger of the two by market cap, and EPR Properties pays a 6.22% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | EPR | |
|---|---|---|
Market Cap | $2.99B | $4.58B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $64.32 |
52-Week Low | $2.78 | $48.71 |
Enterprise Value | $2.58B | $8.09B |
Dividend Yield | — | 6.22% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →